Earnings Call · Q1 FY2025·2025-05-06

Q1 25EPS +4.27%·Rev n/aQ4 24EPS -9.45%·Rev n/aQ3 24EPS +4.76%·Rev n/aQ2 24EPS +6.75%·Rev n/a⚠ consensus missing

Ultragenyx Pharmaceutical Inc. RARE

−4.7%1d on move date−5.1% vs SPY3d+0.1%5d+1.0%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RARE calls or request research access.

More RARE calls Browse calls Request research access